Legacy Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$272K Buy
235
+42
+22% +$49.6K 0.2% 73
2026
Q2
$232K Buy
+193
New +$197K 0.16% 50
2025
Q4
– Sell
-265
Closed -$202K – 51
2025
Q3
$202K Buy
+265
New +$197K 0.15% 50
2025
Q2
– Sell
-538
Closed -$444K – 48
2025
Q1
$444K Buy
538
+23
+4% +$19.1K 0.38% 31
2024
Q4
$398K Buy
515
+134
+35% +$111K 0.34% 39
2024
Q3
$338K Buy
+381
New +$343K 0.29% 44

Other funds holding LLY

Legacy Advisory Services's LLY Position: Q3 2026 in Review

Legacy Advisory Services increased its Eli Lilly (LLY) stake by 22% in Q3 2026, buying an estimated $49.6K and bringing the position to 235 shares worth $272K. The position accounts for 0.2% of the portfolio, ranked #73.

Legacy Advisory Services first reported a position in LLY in Q3 2024 and has held it in 6 quarters since. The position peaked at $444K in Q1 2025. 1,741 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Legacy Advisory Services held 235 shares of Eli Lilly worth $272K as of Q3 2026.
  • Legacy Advisory Services bought 42 Eli Lilly shares in Q3 2026, an estimated $49.6K.
  • Eli Lilly made up 0.2% of Legacy Advisory Services's portfolio in Q3 2026, its #73 holding.
  • Legacy Advisory Services first reported a position in Eli Lilly in Q3 2024 and has held it in 6 quarters since.
  • Legacy Advisory Services's Eli Lilly position peaked at $444K in Q1 2025.
  • 1,741 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Legacy Advisory Services's 13F filing for Q3 2026, filed 20 Oct 2026.